0001209191-19-004240.txt : 20190117
0001209191-19-004240.hdr.sgml : 20190117
20190117164832
ACCESSION NUMBER: 0001209191-19-004240
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190116
FILED AS OF DATE: 20190117
DATE AS OF CHANGE: 20190117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Palczuk Linda
CENTRAL INDEX KEY: 0001717580
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38529
FILM NUMBER: 19531387
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verrica Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660334
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463137900
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 NORTH HIGH STREET
STREET 2: SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
BUSINESS PHONE: 484-453-3300
MAIL ADDRESS:
STREET 1: 10 NORTH HIGH STREET
STREET 2: SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-16
0
0001660334
Verrica Pharmaceuticals Inc.
VRCA
0001717580
Palczuk Linda
C/O VERRICA PHARMACEUTICALS INC.
10 NORTH HIGH STREET, SUITE 200
WEST CHESTER
PA
19380
0
1
0
0
Chief Operating Officer
Common Stock
2019-01-16
4
P
0
3000
10.53
A
8500
D
The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $10.40 to $10.659, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Consists of 3,000 shares of common stock held by Ms. Palczuk and 5,500 shares of common stock held by Ms. Palczuk jointly with her spouse.
/s/ Mark Ballantyne, Attorney-in-Fact
2019-01-17